The Indoleamine 2,3-dioxygenase Inhibitor 1-methyl-tryptophan Suppresses Mitochondrial Function, Induces Aerobic Glycolysis and Decreases Interleukin-10 Production in Human Lymphocytes

REFERENCES

• Alexander, A.M., Crawford, M., Bertera, S., Rudert, W.A., Takikawa, O., Robbins, P.D., Trucco, M. (2002). Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51:356–365.
   PubMed Web of Science ®Google Scholar
• Berridge, M.V., Herst, P.M., Tan, A.S. (2005). Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol. Annu. Rev. 11:127–152.
   PubMedGoogle Scholar
• Beutelspacher, S.C., Pillai, R., Watson, M.P., Tan, P.H., Tsang, J., McClure, M.O., George, A.J., Larkin, D.F. (2006). Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur. J. Immunol. 36:690–700.
   PubMed Web of Science ®Google Scholar
• Bozza, S., Fallarino, F., Pitzurra, L., Zelante, T., Montagnoli, C., Bellocchio, S., Mosci, P., Vacca, C., Puccetti, P., Romani, L. (2005). A crucial role for tryptophan catabolism at the host/Candida albicans interface. J. Immunol. 174:2910–2918.
   PubMed Web of Science ®Google Scholar
• Cairns, R.A., Harris, I.S., Mak, T.W. (2011). Regulation of cancer cell metabolism. Nat. Rev. Cancer 11:85–95.
   PubMed Web of Science ®Google Scholar
• Chaudhry, A., Samstein, R.M., Treuting, P., Liang, Y., Pils, M.C., Heinrich, J.M., Jack, R.S., Wunderlich, F.T., Bruning, J.C., Muller, W., Rudensky, A.Y. (2011). Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34:566–578.
   PubMed Web of Science ®Google Scholar
• Christofk, H.R., Vander Heiden, M.G., Harris, M.H., Ramanathan, A., Gerszten, R.E., Wei, R., Fleming, M.D., Schreiber, S.L., Cantley, L.C. (2008). The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–233.
   PubMed Web of Science ®Google Scholar
• Couper, K.N., Blount, D.G., Riley, E.M. (2008). IL-10: the master regulator of immunity to infection. J. Immunol. 180:5771–5777.
   PubMed Web of Science ®Google Scholar
• Curti, A., Trabanelli, S., Salvestrini, V., Baccarani, M., Lemoli, R.M. (2009). The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood 113:2394–2401.
   PubMed Web of Science ®Google Scholar
• Dufort, F.J., Bleiman, B.F., Gumina, M.R., Blair, D., Wagner, D.J., Roberts, M.F., Abu-Amer, Y., Chiles, T.C. (2007). Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J. Immunol. 179:4953–4957.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis, T., Liakopoulos, V., Antoniadi, G., Stefanidis, I., Galaktidou, G. (2011). Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination. Vaccine 29:2242–2247.
   PubMed Web of Science ®Google Scholar
• Fallarino, F., Grohmann, U., You, S., McGrath, B.C., Cavener, D.R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M.L., Volpi, C., (2006). The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176:6752–6761.
   PubMed Web of Science ®Google Scholar
• Fox, C.J., Hammerman, P.S., Thompson, C.B. (2005). Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5:844–852.
   PubMed Web of Science ®Google Scholar
• Guo, F., Cavener, D.R. (2007). The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab. 5: 103–114.
   PubMed Web of Science ®Google Scholar
• Gurtner, G.J., Newberry, R.D., Schloemann, S.R., McDonald, K.G., Stenson, W.F. (2003). Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125:1762–1773.
   PubMed Web of Science ®Google Scholar
• Jia, L., Schweikart, K., Tomaszewski, J., Page, J.G., Noker, P.E., Buhrow, S.A., Reid, J.M., Ames, M.M., Munn, D.H. (2008). Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of toxicity due to saturating absorption. Food Chem. Toxicol. 46:203–211.
   PubMed Web of Science ®Google Scholar
• King, N.J., Thomas, S.R. (2007). Molecules in focus: indoleamine 2,3-dioxygenase. Int. J. Biochem. Cell Biol. 39:2167–2172.
   PubMed Web of Science ®Google Scholar
• Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., Bechmann, I. (2005). Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 19:1347–1349.
   PubMed Web of Science ®Google Scholar
• Li, Y., Tredget, E.E., Ghaffari, A., Lin, X., Kilani, R.T., Ghahary, A. (2006). Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. J. Invest. Dermatol. 126:128–136.
   PubMed Web of Science ®Google Scholar
• Maciver, N.J., Jacobs, S.R., Wieman, H.L., Wofford, J.A., Coloff, J.L., Rathmell, J.C. (2008). Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol. 84:949–957.
   PubMed Web of Science ®Google Scholar
• Marie, S.K., Shinjo, S.M. (2011). Metabolism and brain cancer. Clinics (Sao Paulo) 66 Suppl. 1:33–43.
   Google Scholar
• Mellor, A.L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D., Munn, D.H. (2001). Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2:64–68.
   PubMed Web of Science ®Google Scholar
• Michalek, R.D., Gerriets, V.A., Jacobs, S.R., Macintyre, A.N., MacIver, N.J., Mason, E.F., Sullivan, S.A., Nichols, A.G., Rathmell, J.C. (2011). Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186:3299–3303.
   PubMed Web of Science ®Google Scholar
• Muller, A.J., Sharma, M.D., Chandler, P.R., Duhadaway, J.B., Everhart, M.E., Johnson, B.A., 3rd, Kahler, D.J., Pihkala, J., Soler, A.P., Munn, D.H., (2008). Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. Proc. Natl. Acad. Sci. USA 105: 17073–17078.
   PubMed Web of Science ®Google Scholar
• Munn, D.H., Mellor, A.L. (2007). Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117:1147–1154.
   PubMed Web of Science ®Google Scholar
• Munn, D.H., Zhou, M., Attwood, J.T., Bondarev, I., Conway, S.J., Marshall, B., Brown, C., Mellor, A.L. (1998). Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191–1193.
   PubMed Web of Science ®Google Scholar
• Park, Y.S., Bae, J.H., Son, C.H., Lee, K.S., Kim, W., Jung, M.H., Yang, K., Kim, S.H., Kang, C.D. (2011). Cyclophosphamide potentiates the antitumor effect of immunization with injection of immature dendritic cells into irradiated tumor. Immunol. Invest. 40:383–399.
   PubMed Web of Science ®Google Scholar
• Rubtsov, Y.P., Rasmussen, J.P., Chi, E.Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W.R., Jr., (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28:546–558.
   PubMed Web of Science ®Google Scholar
• Sabat, R., Grutz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., Geginat, J. (2010). Biology of interleukin-10. Cytokine Growth Factor Rev. 21:331–344.
   PubMed Web of Science ®Google Scholar
• Sakurai, K., Zou, J.P., Tschetter, J.R., Ward, J.M., Shearer, G.M. (2002). Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 129:186–196.
   PubMed Web of Science ®Google Scholar
• Seo, S.K., Choi, J.H., Kim, Y.H., Kang, W.J., Park, H.Y., Suh, J.H., Choi, B.K., Vinay, D.S., Kwon, B.S. (2004). 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 10:1088–1094.
   PubMed Web of Science ®Google Scholar
• Sharma, M.D., Baban, B., Chandler, P., Hou, D.Y., Singh, N., Yagita, H., Azuma, M., Blazar, B.R., Mellor, A.L., Munn, D.H. (2007). Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117:2570–2582.
   PubMed Web of Science ®Google Scholar
• Sharma, M.D., Hou, D.Y., Liu, Y., Koni, P.A., Metz, R., Chandler, P., Mellor, A.L., He, Y., Munn, D.H. (2009). Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 113:6102–6111.
   PubMed Web of Science ®Google Scholar
• Shi, L.Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D.R., Chi, H. (2011). HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208:1367–1376.
   PubMed Web of Science ®Google Scholar
• Uyttenhove, C., Pilotte, L., Theate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., Van den Eynde, B.J. (2003). Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9:1269–1274.
   PubMed Web of Science ®Google Scholar
• Vander Heiden, M.G., Cantley, L.C., Thompson, C.B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033.
   PubMed Web of Science ®Google Scholar
• Xiao, F., Huang, Z., Li, H., Yu, J., Wang, C., Chen, S., Meng, Q., Cheng, Y., Gao, X., Li, J., (2011). Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 60:746–756.
   PubMed Web of Science ®Google Scholar
• Zhao, Z.G., Xu, W., Sun, L., You, Y., Li, F., Li, Q.B., Zou, P. (2012). Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol. Invest. 41:183–198.
   PubMed Web of Science ®Google Scholar